Astoria-Pacific, Inc.

Click Here To EMAIL INQUIRY
Web: http://www.astoria-pacific.com
E-Mail:
Address: PO Box 830, Clakamas, Oregon 97015, USA
Phone: +1-(503)-657-3010, 800-536-3111 | Fax: +1-(503)-655-7367 | Map/Directions >>

Profile: Astoria-Pacific, Inc. manufactures continuous flow analyzers. We provide various models of chemistry analyzers for clinical use. Our phenylalanine test automates the measure of phenylalanine in the newborn blood sample by first diluting and then dialyzing to remove interfering substances. The phenylalanine in the sample then reacts with ninhydrin in the presence of a dipietide to form a fluorescent end product. The amount of fluorescence is proportional to the phenylalanine concentration in the sample. We offer products for newborn screening, environmental analysis, oceanographic testing and other applications. Astoria analyzer is a versatile system and it is perfect for testing multiple tests simultaneously and for the purpose of research & development.

The company was founded in 1990, has revenues of USD 5-10 Million, has ~40 employees and is CE certified.

FDA Registration Number: 3050015

15 Products/Services (Click for related suppliers)

• Biotinidase Test System (FDA Code: NAK / 862.1118)

The biotinidase test system is an in vitro diagnostic device intended to measure the activity of the enzyme biotinidase in blood. Measurements of biotinidase are used in the treatment and diagnosis of biotinidase deficiency, an inborn error of metabolism in infants, characterized by the inability to utilize dietary protein bound vitamin or to recycle endogenous biotin. The deficiency may result in irreversible neurological impairment.

• Continuous Flow Sequential Multiple Chemistry Analyzer (FDA Code: JJC / 862.2150)

A continuous flow sequential multiple chemistry analyzer for clinical use is a modular analytical instrument intended to simultaneously perform multiple chemical procedures using the principles of automated continuous flow systems. This device is intended for use in conjunction with certain materials to measure a variety of analytes.

• Diagnostic Reagents

• Fluorometers (FDA Code: JZT / 866.4520)

Immunofluorometer equipment for clinical use with its electrical power supply is a device used to measure the fluorescence of fluorochrome-labeled antigen-antibody complexes. The concentration of these complexes may be measured by means of reflected light. A beam of light is passed through a solution in which a fluorochrome has been selectively attached to serum protein antibody molecules in suspension. The amount of light emitted by the fluorochrome label is detected by a photodetector, which converts light energy into electrical energy. The amount of electrical energy registers on a readout system such as a digital voltmeter or a recording chart. This electrical readout is called the fluorescence value and is used to measure the concentration of antigen-antibody complexes.

• Free Tyrosine 1-Nitroso-2-Naphthol (Fluorometric) (FDA Code: CDR / 862.1730)

A free tyrosine test system is a device intended to measure free tyrosine (an amono acid) in serum and urine. Measurements obtained by this device are used in the diagnosis and treatment of diseases such as congenital tyrosinemia (a disease that can cause liver/kidney disorders) and as an adjunct to the measurement of phenylalanine in detecting congenital phenylketonuria (a disease that can cause brain damage).

• Galactose-1-Phosphate Uridyltransferase (FDA Code: KQP / 862.1315)

A galactose-1-phosphate uridyl transferase test system is a device intended to measure the activity of the enzyme galactose-1-phosphate uridyl transferase in erythrocytes (red blood cells). Measurements of galactose-1-phosphate uridyl transferase are used in the diagnosis and treatment of the hereditary disease galactosemia (disorder of galactose metabolism) in infants.

• Micro Chemistry Analyzer (FDA Code: JJF / 862.2170)

A micro chemistry analyzer for clinical use is a device intended to duplicate manual analytical procedures by performing automatically various steps such as pipetting, preparing filtrates, heating, and measuring color intensity. The distinguishing characteristic of the device is that it requires only micro volume samples obtainable from pediatric patients. This device is intended for use in conjunction with certain materials to measure a variety of analytes.

• Microplate

• Microplate Immunoassay System

• Ninhydrin and L-Leucyl-L-Alanine Test (FDA Code: JNB / 862.1555)

A phenylalanine test system is a device intended to measure free phenylalanine (an amino acid) in serum, plasma, and urine. Measurements of phenylalanine are used in the diagnosis and treatment of congenital phenylketonuria which, if untreated, may cause mental retardation.

• Photometer

• Quantitative Glucose-6-Phosphate Dehydrogenase (Erythrocytic) (FDA Code: JBL / 864.7360)

An erythrocytic glucose-6-phosphate dehydrogenase assay is a device used to measure the activity of the enzyme glucose-6-phosphate dehydrogenase or of glucose-6-phosphate dehydrogenase isoenzymes. The results of this assay are used in the diagnosis and treatment of nonspherocytic congenital hemolytic anemia or drug-induced hemolytic anemia associated with a glucose-6-phosphate dehydrogenase deficiency. This generic device includes assays based on fluorescence, electrophoresis, methemoglobin reduction, catalase inhibition, and ultraviolet kinetics.

• Reagents

• Red Blood Cell Storage Solutions

• Vitamins